Global Hyaluronic Acid-based Dermal Fillers Market 2024-2034: Single-Phase Products Have Emerged as a Dominant Segment; Wrinkle Correction Applications Leads in Revenue Generation [Yahoo! ...
Anika Therapeutics Inc. (ANIK)
Last anika therapeutics inc. earnings: 2/20 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.anikatherapeutics.com/investor-relations
Company Research
Source: Yahoo! Finance
Market Analysis & Forecast to 2024-2034" report has been added to ResearchAndMarkets.com's offering. In this comprehensive analysis of the burgeoning hyaluronic acid-based dermal fillers market, the study projects an upward trajectory, predicting the industry to escalate to a valuation of USD 12.39 billion by the year 2034, with a Compound Annual Growth Rate (CAGR) of 8.96% from 2024 to 2034. This substantial growth is attributed to a series of factors, including the rising demand for minimally invasive cosmetic procedures and an increased awareness of aesthetic treatments. The Surge in Non-invasive Aesthetic Procedures Catalyzes Industry Expansion The surge in customer demand for non-surgical enhancement options has significantly fueled the market's growth, leading to cutting-edge product innovations and approval of novel treatments by regulatory authorities. Report Highlights Key Market Segments and Trends Single-phase products have emerged as a dominant segment, driven
Show less
Read more
Impact Snapshot
Event Time:
ANIK
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ANIK alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ANIK alerts
High impacting Anika Therapeutics Inc. news events
Weekly update
A roundup of the hottest topics
ANIK
News
- Anika Therapeutics (NASDAQ:ANIK) shareholders have endured a 37% loss from investing in the stock three years ago [Yahoo! Finance]Yahoo! Finance
- Anika to Issue First Quarter 2024 Financial Results on Wednesday, May 8, 2024GlobeNewswire
- Anika to Participate in the 23rd Annual Needham Virtual Healthcare Conference [Yahoo! Finance]Yahoo! Finance
- Anika to Participate in the 23rd Annual Needham Virtual Healthcare ConferenceGlobeNewswire
- Anika Therapeutics, Inc. (NASDAQ: ANIK) had its price target raised by analysts at Barrington Research from $29.00 to $37.00. They now have an "outperform" rating on the stock.MarketBeat
ANIK
Earnings
- 3/13/24 - Beat
ANIK
Sec Filings
- 4/26/24 - Form 10-K/A
- 4/5/24 - Form SC
- 3/19/24 - Form 4
- ANIK's page on the SEC website